ATE375514T1 - Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion - Google Patents

Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion

Info

Publication number
ATE375514T1
ATE375514T1 AT00910338T AT00910338T ATE375514T1 AT E375514 T1 ATE375514 T1 AT E375514T1 AT 00910338 T AT00910338 T AT 00910338T AT 00910338 T AT00910338 T AT 00910338T AT E375514 T1 ATE375514 T1 AT E375514T1
Authority
AT
Austria
Prior art keywords
methods
compounds
cruzi infection
compositions
trypanosoma cruzi
Prior art date
Application number
AT00910338T
Other languages
English (en)
Inventor
Steven Reed
Yasir Skeiky
Michael Lodes
Raymond Houghton
John Smith
Patricia Mcneill
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE375514T1 publication Critical patent/ATE375514T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
AT00910338T 1999-02-24 2000-02-24 Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion ATE375514T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/256,976 US6419933B1 (en) 1995-11-14 1999-02-24 Compounds and methods for the detection and prevention of T.cruzi infection

Publications (1)

Publication Number Publication Date
ATE375514T1 true ATE375514T1 (de) 2007-10-15

Family

ID=22974378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00910338T ATE375514T1 (de) 1999-02-24 2000-02-24 Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion

Country Status (9)

Country Link
US (1) US6419933B1 (de)
EP (1) EP1155322B1 (de)
JP (1) JP2002537783A (de)
AT (1) ATE375514T1 (de)
AU (1) AU3245000A (de)
CA (1) CA2362608A1 (de)
DE (1) DE60036692D1 (de)
MX (1) MXPA01008621A (de)
WO (1) WO2000050897A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875584B1 (en) * 1999-03-02 2005-04-05 University Of Georgia Research Foundation, Inc. Prophylactic and therapeutic immunization against protozoan infection and disease
CA2563796A1 (en) * 2004-04-23 2005-11-24 The University Of Georgia Research Foundation, Inc. Diagnostic assay for trypanosoma cruzi infection
US7780969B2 (en) * 2005-07-15 2010-08-24 University Of Georgia Research Foundation, Inc. Trypanosoma cruzi proteome compositions and methods
WO2007056114A2 (en) * 2005-11-03 2007-05-18 Inbios International, Inc. Compositions and methods for the detection of trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
US20080107692A1 (en) * 2006-11-02 2008-05-08 Infectious Disease Research Institute Compositions and methods for the detection of trypanosoma cruzi infection
WO2008057961A2 (en) * 2006-11-02 2008-05-15 Infectious Disease Research Institute Compositions and methods for the detection of trypanosoma cruzi infection
EP2182979A4 (de) * 2007-07-30 2010-09-08 Univ Georgia Diagnostischer assay für eine infektion mit trypanosoma cruzi
ES2539026T3 (es) * 2007-12-27 2015-06-25 Abbott Laboratories Anticuerpos anti-T. cruzi y métodos de uso
FR2945290A1 (fr) * 2009-05-07 2010-11-12 Maan Zrein Anticorps biomarqueur et dispositif de diagnostic pour la detection de certaines maladies auto-immunes
ES2373262B1 (es) * 2010-07-16 2013-05-06 Consejo Superior De Investigaciones Científicas (Csic) Método de diagnóstico diferencial de la enfermedad de chagas.
ITUA20161850A1 (it) * 2016-03-21 2017-09-21 Fluidia S R L Metodo per la valutazione quantitativa in biologico, della forma fosforilata e non fosforilata di RKIP

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (de) 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US5916572A (en) 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection

Also Published As

Publication number Publication date
AU3245000A (en) 2000-09-14
DE60036692D1 (de) 2007-11-22
WO2000050897A1 (en) 2000-08-31
JP2002537783A (ja) 2002-11-12
US6419933B1 (en) 2002-07-16
EP1155322B1 (de) 2007-10-10
MXPA01008621A (es) 2002-04-24
CA2362608A1 (en) 2000-08-31
EP1155322A1 (de) 2001-11-21

Similar Documents

Publication Publication Date Title
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
DK0528859T3 (da) Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer
NO870412D0 (no) Peptider.
DE60036692D1 (de) Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion
DK1584685T3 (da) Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
DE69533295D1 (de) Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
NO975598L (no) Monoklonale ape-antistoffer som er spesifikke for primatiserte humane B7.1- og/eller B7.2-former, samt farmasöytiske sammensetninger
NO912369D0 (no) Meningokokk-klasse-1-ytre-membranvaksine.
DE69939430D1 (de) Diagnose von Virus Infektion assoziierten Krebs mit Aglycoprotein 10B
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
MX9803841A (es) Compuestos y metodos para la deteccion y prevencion de infeccion por t. cruzi.
DE60042816D1 (de) T-helferzellen-epitope
DE60019178D1 (de) Neue Antigenklasse von Geflügelreoviren
BR0109164A (pt) Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos
BR9813637A (pt) Compostos e métodos para a detecção e prevençãode infecção por t. cruzi
DE69836976D1 (de) Neospora impstoff
EP1700122A4 (de) Immunoassays, haptene, immunogene und antikörper für anti-hiv-therapeutika
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
DE69231495D1 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
DK1035133T3 (da) Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons
EP0670494A3 (de) Immunotest für Anti-Treponema-Pallidum Antikörper.
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
DK1077999T3 (da) Moraxella catarrhalis-proteiner
AR020852A1 (es) Antigenos de vacuna de leptospira para la prevencion de leptospirosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties